查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區非侵入性產前檢測 (NIPT) 市場：按測試方法、按平台、按最終用戶、按應用、按國家/地區 - 分析和預測 (2023-2033)
市場調查報告書
商品編碼
1599902

亞太地區非侵入性產前檢測 (NIPT) 市場：按測試方法、按平台、按最終用戶、按應用、按國家/地區 - 分析和預測 (2023-2033)

Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 68 Pages | 商品交期: 1-5個工作天內

價格

2023年，亞太地區非侵入性產前檢測（NIPT）市場規模達6.592億美元。

預計到 2033 年，該市場將達到 27.673 億美元，2023-2033 年預測期間複合年成長率為 15.43%。支持性醫療保健政策的採用、篩檢測試保險覆蓋範圍的擴大、技術的持續進步、整個全部區域機會的擴大以及準媽媽和醫療保健提供者對非侵入性檢測方法的日益偏好是推動亞太地區非侵入性檢測的關鍵因素。

主要市場統計數據
預測期 2023-2033
2023年評估 6.592 億美元
2033 年預測 27.673 億美元
複合年成長率 15.43%

由於該地區醫療保健支出的增加以及對複雜產前篩檢技術的了解不斷成長，亞太地區無創產前檢測 (NIPT) 市場正在顯著擴張。由於其準確性、安全性和非侵入性，NIPT 作為一項用於檢查母血中胎兒遊離 DNA 的突破性技術而變得越來越受歡迎。它在懷孕期間經常用於識別染色體異常，例如帕陶綜合症、愛德華茲綜合症和唐氏症。

母親年齡的老化、先進遺傳技術的可用性以及準確及時的產前診斷的需求正在推動市場成長。許多亞太國家產前檢測保險覆蓋範圍的擴大和醫療保健改革的實施進一步支持了 NIPT 的採用。

市場上的主要企業專注於開發負擔得起的測試解決方案，以服務該地區不同的人口和廣泛的收入水平。國際公司和當地醫療保健提供者之間的夥伴關係正在提高人們的意識和可及性，特別是在開發中國家。

該報告調查了亞太地區無創產前檢測 (NIPT) 市場，按測試方法、平台、最終用戶、應用、國家和市場參與者提供了市場概況，並提供了公司概況、 ETC。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研究發展回顧
  • 監管狀況
  • 贖回場景
  • 市場動態概覽

第2章 區域

  • 促進因素和抑制因素
  • 區域概況
  • 亞太地區

第3章市場－競爭基準化分析與公司概況

  • 競爭格局
    • BGI Genomics
    • Annoroad Gene Technology

第4章調查方法

Product Code: BHL2407SS

Introduction to Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market

The Asia-Pacific NIPT market was valued at $659.2 million in 2023 and is expected to reach $2,767.3 million by 2033, registering a CAGR of 15.43% during the forecast period 2023-2033. The adoption of supportive healthcare policies, the growing inclusion of screening procedures in insurance coverage, ongoing technological advancements, the expansion of commercial opportunities throughout the region, and the growing preference for non-invasive testing methods among expectant parents and healthcare providers are the main factors propelling the APAC NIPT market.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$659.2 Million
2033 Forecast$2,767.3 Million
CAGR15.43%

The market for non-invasive prenatal testing (NIPT) in Asia-Pacific is expanding significantly due to increased healthcare spending in the region and growing knowledge of sophisticated prenatal screening techniques. Because of its great accuracy, safety, and non-invasiveness, NIPT-a ground-breaking technology that examines cell-free fetal DNA from maternal blood-is becoming more and more popular. During pregnancy, it is frequently used to identify chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome.

Growing maternal age, the use of sophisticated genetic technologies, and the need for accurate and timely prenatal diagnostics are driving the market's growth. The adoption of NIPT is being further supported by the expansion of insurance coverage for prenatal care and the implementation of healthcare reforms in many Asia-Pacific nations.

The market's major players are concentrating on creating affordable testing solutions to serve the region's diverse population and range of income levels. Partnerships between international corporations and regional healthcare providers are increasing awareness and accessibility, especially in developing nations.

As prenatal health awareness rises and healthcare infrastructure improves, the APAC NIPT market is expected to grow rapidly. It will be crucial in improving maternal and fetal health outcomes throughout the area.

Market Segmentation:

Segmentation 1: by Application

  • Trisomy Detection
  • Microdeletion Detection
  • Sex Chromosome Aneuploidy Detection
  • Others

Segmentation 2: by End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

Segmentation 3: by Platform

  • NGS
  • PCR
  • Others

Segmentation 4: by Method

  • cfDNA
  • FCMB

Segmentation 5: by Country

  • China
  • India
  • Japan
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • BGI Genomics
  • Annoroad Gene Technology

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
    • 1.1.2 Expanding Applications in NIPT Products
  • 1.2 Supply Chain Overview
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
    • 1.4.1 Regulatory Scenario in China
    • 1.4.2 Regulatory Scenario in India
    • 1.4.3 Regulatory Scenario in Australia
    • 1.4.4 Regulatory Scenario in Japan
  • 1.5 Reimbursement Scenario
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 High Incidence of Genetic Disorders
      • 1.6.1.2 Rising Maternal Age
      • 1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
      • 1.6.1.4 Increased Emphasis on Early Detection and Prevention
    • 1.6.2 Market Restraints
      • 1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
      • 1.6.2.2 Lack of Awareness Regarding NIPT
      • 1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia
      • 1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)

2 Regions

  • 2.1 Drivers and Restraints
  • 2.2 Regional Summary
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 China
    • 2.3.7 India
    • 2.3.8 Japan
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 BGI Genomics
      • 3.1.1.1 Overview
      • 3.1.1.2 Product Portfolio
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers
      • 3.1.1.5 Key Personnel
      • 3.1.1.6 Analyst View
    • 3.1.2 Annoroad Gene Technology
      • 3.1.2.1 Overview
      • 3.1.2.2 Product Portfolio
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers
      • 3.1.2.5 Key Personnel
      • 3.1.2.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 2: Asia-pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
  • Figure 5: Non-Invasive Prenatal Testing Market, Recent Developments, 2023
  • Figure 6: Supply Chain of NIPT Market
  • Figure 7: NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
  • Figure 8: NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
  • Figure 9: Reimbursement Scenario in Major Countries of the NIPT Market
  • Figure 10: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 11: Age of Mother at Childbirth over the Years
  • Figure 12: Reimbursement Scenario in Major Countries
  • Figure 13: Number of Tests Processed by Natera, Inc., 2018-2020
  • Figure 14: Positives from Data of 75,000 NIPT Tests Showing False Positives
  • Figure 15: Recent Developments in APAC by Key Companies
  • Figure 16: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 17: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033
  • Figure 18: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033
  • Figure 19: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 20: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 21: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 22: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 23: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 26: Share of Strategic Initiatives
  • Figure 27: Data Triangulation
  • Figure 28: Top-Down and Bottom-Up
  • Figure 29: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Non-Invasive Prenatal Testing Market, Opportunities
  • Table 3: Key Companies' Partnerships and Alliances
  • Table 4: NIPT Tests in the NIPT Market and their Corresponding Applications
  • Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age
  • Table 6: Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
  • Table 7: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
  • Table 8: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 9: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 10: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 11: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 12: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 13: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 14: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 15: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 16: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 17: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 18: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 19: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 20: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 21: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 22: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 23: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 26: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 27: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 28: Market Share (2022)